Skip to main content
SpringerLink
Log in

Staging and Reporting of Renal Cell Carcinomas

  • Chapter
  • First Online:
Kidney Cancer

  • 1011 Accesses

Abstract

This chapter is devoted to staging and reporting renal cell carcinoma (RCC) specimens and applies to both radical nephrectomy and partial nephrectomy (including tumorectomy) specimens [1–4]. Main issues to be considered have been covered thoroughly in the literature with significant differences between different AJCC classifications [1–39] (Fig. 21.1). Since January 2018 is the official call for implementing the AJCC Cancer Staging System, 8th Edition, in practice, we will provide along the next pages, a brief discussion of relevant changes incorporated in the 8th Edition as compared to the previous one.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Amin MB, Edge S, Greene F, Byrd DR, Brookland RK et al., editors. American Joint Committee on Cancer (AJCC) staging manual. 8th ed. Switzerland: Springer; 2017.

    Google Scholar 

  2. Trpkov K, Grignon DJ, Bonsib SM, Amin MB, Billis A, Lopez-Beltran A, Samaratunga H, Tamboli P, Delahunt B, Egevad L, Montironi R, Srigley JR, members of the ISUP Renal Tumor Panel. Handling and staging of renal cell carcinoma. The International Society of Urological Pathology Consensus (ISUP) conference recommendations. Am J Surg Pathol. 2013;37:1505–17.

    Article  Google Scholar 

  3. Moch H, Humphrey PA, Ulbright TM, Reuter VE. World Health Organization (WHO) classification of tumours of the urinary system and male genital organs, vol. 8. 4th ed. Lyon: International Agency for Research on Cancer, cop.; 2016.

    Google Scholar 

  4. Delahunt B, Srigley JR, Amin MB, Billis A, Camparo P, Evans AJ, Fleming S, Griffiths D, Lopez-Beltran A, Martignoni G, Moch H, Nacey JN, Zhou M. Invasive carcinoma of renal tubular origin, histopathology reporting guide. 1st ed. Sydney: International Collaboration on Cancer Reporting; 2017. isbn:978-1-925687-00-2.

    Google Scholar 

  5. Bonsib S. Renal veins and venous extension in clear cell renal carcinoma. Mod Pathol. 2007;20:44–53.

    Article  Google Scholar 

  6. Greene F, Page D, Fleming I. American Joint Committee on cancer staging manual. 6th ed. New York: Springer; 2002. p. 131–44.

    Book  Google Scholar 

  7. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. American Joint Committee on Cancer (AJCC) cancer staging manual. 7th ed. Chicago: Springer, Inc; 2010.

    Google Scholar 

  8. Srigley JR, Delahunt B, Eble JN, et al. The International Society of Urological Pathology (ISUP) Vancouver Classification of renal neoplasia. Am J Surg Pathol. 2013;37:1469–89.

    Article  Google Scholar 

  9. Novara G, Ficarra V, Antonelli A, et al. Validation of the 2009 TNM version in a large multi-institutional cohort of patients treated for renal cell carcinoma: are further improvements needed? Eur Urol. 2010;58:588–95.

    Article  Google Scholar 

  10. Lopez-Beltran A, Scarpelli M, Montironi R, Kirkali Z. WHO classification of the renal tumors of the adults. Eur Urol. 2006;49:798–805.

    Article  Google Scholar 

  11. Algaba F, Trias I, Scarpelli M, et al. Handling and pathology reporting of renal tumor specimens. Eur Urol. 2004;45:437–43.

    Article  CAS  Google Scholar 

  12. Higgins JP, McKenney JK, Brooks JD, et al. Recommendations for the reporting of surgically resected specimens of renal cell carcinoma: the Association of Directors of Anatomic and Surgical Pathology. Hum Pathol. 2009;40:456–63.

    Article  Google Scholar 

  13. Lopez-Beltran A, Suzigan S, Montironi R, et al. Multilocular cystic renal cell carcinoma: a report of 45 cases of a kidney tumor of low malignant potential. Am J Clin Pathol. 2006;125:217–22.

    Article  Google Scholar 

  14. Eble JN. Recommendations for examining and reporting tumor-bearing kidney specimens from adults. Semin Diagn Pathol. 1998;15:77–82.

    CAS  PubMed  Google Scholar 

  15. Bonsib SM. The renal sinus is the principal invasive pathway: a prospective study of 100 renal cell carcinomas. Am J Surg Pathol. 2004;28:1594–600.

    Article  Google Scholar 

  16. Thompson RH, Leibovich BC, Cheville JC, et al. Is renal sinus fat invasion the same as perinephric fat invasion for pT3a renal cell carcinoma? J Urol. 2005;174:1218–21.

    Article  Google Scholar 

  17. Grignon D, Paner GP. Renal cell carcinoma and the renal sinus. Adv Anat Pathol. 2007;14:63–8.

    Article  Google Scholar 

  18. Montironi R, Cheng L, Scarpelli M, Lopez-Beltran A. Pathology and genetics: tumours of the urinary system and male genital system: clinical implications of the 4th Edition of the WHO classification and beyond. Eur Urol. 2016;70(1):120–3. https://doi.org/10.1016/j.eururo.2016.03.011.

    Article  PubMed  Google Scholar 

  19. Bonsib SM. Renal lymphatics, and lymphatic involvement in sinus vein invasive (pT3b) clear cell renal cell carcinoma: a study of 40 cases. Mod Pathol. 2006;19:746–53.

    Article  Google Scholar 

  20. Bonsib SM. Renal veins and venous extension in clear cell renal cell carcinoma. Mod Pathol. 2007;20:44–53.

    Article  Google Scholar 

  21. Lopez-Beltran A, Cheng L, Raspollini MR, Montironi R. SMARCB1/INI1 genetic alterations in renal medullary carcinomas. Eur Urol. 2016;69(6):1062–4. https://doi.org/10.1016/j.eururo.2016.01.002.

    Article  CAS  PubMed  Google Scholar 

  22. Thompson RH, Blute ML, Krambeck AE, et al. Patients with pT1 renal cell carcinoma who die from disease after nephrectomy may have unrecognized renal sinus fat invasion. Am J Surg Pathol. 2007;31:1089–93.

    Article  Google Scholar 

  23. Frank I, Blute ML, Cheville JC, et al. Solid renal tumors: an analysis of pathological features related to tumor size. J Urol. 2003;170:2217–20.

    Article  Google Scholar 

  24. Lopez-Beltran A, Kirkali Z, Montironi R, Blanca A, Algaba F, Scarpelli M, Yorukoglu K, Hartmann A, Cheng L. Unclassified renal cell carcinoma: a report of 56 cases. BJU Int. 2012;110(6):786–93. https://doi.org/10.1111/j.1464-410X.2012.10934.x.

    Article  PubMed  Google Scholar 

  25. Verine J, Pluvinage A, Bousquet G, et al. Hereditary renal cancer syndromes: an update of a systematic review. Eur Urol. 2010;58:701–10.

    Article  Google Scholar 

  26. Richstone L, Scherr DS, Reuter VR, et al. Multifocal renal cortical tumors: frequency, associated clinicopathological features and impact on survival. J Urol. 2004;171:615–20.

    Article  Google Scholar 

  27. Zini L, Destrieux-Garnier L, Leroy X, et al. Renal vein ostium wall invasion of renal cell carcinoma with an inferior vena cava tumor thrombus: prediction by renal and vena caval vein diameters and prognostic significance. J Urol. 2008;179:450–4.

    Article  Google Scholar 

  28. Han KR, Bui MH, Pantuck AJ, et al. TNM T3a renal cell carcinoma: adrenal gland involvement is not the same as renal fat invasion. J Urol. 2003;169:899–903.

    Article  Google Scholar 

  29. Conti A, Santoni M, Sotte V, Burattini L, Scarpelli M, Cheng L, Lopez-Beltran A, Montironi R, Cascinu S, Muzzonigro G, Lund L. Small renal masses in the era of personalized medicine: tumor heterogeneity, growth kinetics, and risk of metastasis. Urol Oncol. 2015;33(7):303–9.

    Article  Google Scholar 

  30. Thompson RH, Leibovich BC, Cheville JC, et al. Should direct ipsilateral adrenal invasion from renal cell carcinoma be classified as pT3a? J Urol. 2005;173:918–21.

    Article  Google Scholar 

  31. Raspollini MR, Montagnani I, Montironi R, Cheng L, Martignoni G, Minervini A, Serni S, Nicita G, Carini M, Lopez-Beltran A. A contemporary series of renal masses with emphasis on recently recognized entities and tumors of low malignant potential: A report based on 624 consecutive tumors from a single tertiary center. Pathol Res Pract. 2017;213(7):804–8.

    Article  Google Scholar 

  32. Mehta V, Mudaliar K, Ghai R, et al. Renal lymph nodes for tumor staging: appraisal of 861 adult nephrectomies with microscopic examination of hilar fat. Arch Pathol Lab Med. 2013;137:1584.

    Article  Google Scholar 

  33. Terrone C, Guercio S, De Luca S, et al. The number of lymph nodes examined and staging accuracy in renal cell carcinoma. BJU Int. 2003;91:37–40.

    Article  CAS  Google Scholar 

  34. Crispen PL, Breau RH, Allmer C, et al. Lymph node dissection at the time of radical nephrectomy for high-risk clear cell renal cell carcinoma: indications and recommendations for surgical templates. Eur Urol. 2011;59:18–23.

    Article  Google Scholar 

  35. Shuch B, Amin A, Armstrong AJ, Eble JN, Ficarra V, Lopez-Beltran A, Martignoni G, Rini BI, Kutikov A. Understanding pathologic variants of renal cell carcinoma: distilling therapeutic opportunities from biologic complexity. Eur Urol. 2015;67(1):85–97.

    Article  Google Scholar 

  36. Delahunt B, Cheville JC, Martignoni G, et al. The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters. Am J Surg Pathol. 2013;37:1490–504.

    Article  Google Scholar 

  37. Przybycin CG, McKenney JK, Reynolds JP, et al. Rhabdoid differentiation is associated with aggressive behavior in renal cell carcinoma: a clinicopathologic analysis of 76 cases with clinical follow-up. Am J Surg Pathol. 2014;38:1260–5.

    PubMed  Google Scholar 

  38. Reuter VE, Argani P, Zhou M, Delahunt B, Amin MB, Epstein JI, Ulbright TM, Humphrey PA, Egevad L, Montironi R, Grignon D, Trpkov K, Lopez-Beltran A, Berney DM, Srigley JR. Best practice recommendations in the application of immunohistochemistry in kidney tumors; report for the International society of Urological Pathology consensus conference. Am J Surg Pathol. 2014;38:e35–49.

    Article  Google Scholar 

  39. Bijol V, Mendez GP, Hurwitz S, Rennke HG, Nose V. Evaluation of the non-neoplastic pathology in tumor nephrectomy specimens: predicting the risk of progressive failure. Am J Surg Pathol. 2006;30:575–84.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology and Surgery, Cordoba University School of Medicine, Córdoba, Spain

    Antonio Lopez-Beltran

  2. Histopathology and Molecular Diagnostics. University Hospital Careggi, Florence, Italy

    Maria R. Raspollini

  3. Departments of Pathology, Urology, and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USA

    Liang Cheng

  4. Institute of Pathological Anatomy and Histopathology, United Hospitals, Ancona, Italy

    Marina Scarpelli & Rodolfo Montironi

  5. Institute of Pathological Anatomy and Histopathology, University of the Marche Region, Ancona, Italy

    Alessia Cimadamore

  6. Oncology Unit, Macerata Hospital, Macerata, Italy

    Matteo Santoni

  7. Section of Pathological Anatomy, Polytechnic University of the Marche Region, School of Medicine, Ancona, Italy

    Silvia Gasparrini

Authors
  1. Antonio Lopez-Beltran
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maria R. Raspollini
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Liang Cheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Marina Scarpelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Alessia Cimadamore
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Matteo Santoni
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Silvia Gasparrini
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Rodolfo Montironi
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Weill Medical College of Cornell University, Houston, TX, USA

    Mukul K. Divatia

  2. Gulhane Military Medical Academy, School of Medicine, Department of Pathology, Ankara, Turkey

    Ayhan Ozcan

  3. Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Charles C. Guo

  4. Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Weill Medical College of Cornell University, Houston, TX, USA

    Jae Y. Ro

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Lopez-Beltran, A. et al. (2020). Staging and Reporting of Renal Cell Carcinomas. In: Divatia, M., Ozcan, A., Guo, C., Ro, J. (eds) Kidney Cancer. Springer, Cham. https://doi.org/10.1007/978-3-030-28333-9_21

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-28333-9_21

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-28332-2

  • Online ISBN: 978-3-030-28333-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation